Countries China
Neurophth completes Phase III trial enrollment for LHON gene therapy
Neurophth Therapeutics, Inc. ("Neurophth") announced today that the last patient has been enrolled in the Phase III clinical trial for the treatment o...
February 22, 2023 | News
Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio
Duoning obtained exclusive license from BioAces for its cell analysis portfolio Through the partnership, the two companies will advance the development ...
February 21, 2023 | News
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China
-- Clover to leverage its established and growing commercial infrastructure to exclusively distribute Adimmune’s AdimFlu-S (QIS), the only imported q...
February 20, 2023 | News
Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial
BA2101 is the first long-acting anti-IL-4Rα monoclonal antibody that enters the clinical trial stage in the country. It is intended to be used for tr...
February 16, 2023 | News
BioDuro-Sundia Expands Drug Discovery Capacity and Capability
Dr. Xiang Li, President of BioDuro-Sundia Drug Discovery, explains: “At BioDuro-Sundia, we are fully invested in our clientele and pro-actively plann...
February 15, 2023 | News
AnPac Bio-Medical Science Expand Scope of Business in the U.S.
AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China announced ...
February 14, 2023 | News
Boan Biotech's Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial
BA1106 is the first investigational anti-CD25 antibody to start clinical trials in China for treating solid tumors. Focusing on key therapeutic a...
February 13, 2023 | News
Everest Medicines Announces South Korea Grants Fast Track Review Designation to Nefecon for the Treatment of Primary IgA Nephropathy
This demonstrates the urgent unmet medical needs for Nefecon, as Everest also received Priority Review status for the New Drug Application (NDA) of Nefecon...
February 10, 2023 | News
Regulatory filing for house dust mite allergy tablet accepted for review in China
The BLA, for treatment of persistent moderate-to-severe HDM allergic rhinitis in patients aged 12–65 was submitted in late December 2022. S&...
February 03, 2023 | News
Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...
February 03, 2023 | News
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and bro...
February 01, 2023 | News
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and ...
February 01, 2023 | News
Duoning Headquarters in Fengxian Biotechnology Park with Centers for R&D and Technology Applications
The global headquarters, R&D center, and TAC are located in the heart of the Biotechnology Park, with a total planned area of 20,029.8 m2. It...
January 31, 2023 | News
Junshi Biosciences Announces Approval for Marketing of VV116 in China
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company ded...
January 31, 2023 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
- Eva van Pelt Joins Qiagen's Supervisory Board, Bringing a Wealth of Global Leadership Experience in Healthcare and Life Sciences
- Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership
- Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
